EE9700290A - Meetod kinoloonkarboksüülhapete ja naftüridiinkarboksüülhapete saamiseks vabade aluste kujul - Google Patents

Meetod kinoloonkarboksüülhapete ja naftüridiinkarboksüülhapete saamiseks vabade aluste kujul

Info

Publication number
EE9700290A
EE9700290A EE9700290A EE9700290A EE9700290A EE 9700290 A EE9700290 A EE 9700290A EE 9700290 A EE9700290 A EE 9700290A EE 9700290 A EE9700290 A EE 9700290A EE 9700290 A EE9700290 A EE 9700290A
Authority
EE
Estonia
Prior art keywords
carboxylic acid
acid salt
acids
quinolone carboxylic
carboxylic acids
Prior art date
Application number
EE9700290A
Other languages
English (en)
Other versions
EE03522B1 (et
Inventor
Jay Dozeman Gary
Thomas Porter Kenneth
Norton Wemple James
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of EE9700290A publication Critical patent/EE9700290A/et
Publication of EE03522B1 publication Critical patent/EE03522B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
EE9700290A 1995-05-26 1996-04-26 Meetod kinoloonkarboksüülhapete ja naftüridiinkarboksüülhapete saamiseks vabade aluste kujul EE03522B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/452,208 US5602254A (en) 1995-05-26 1995-05-26 Method for making quinoline carboxylic acids or naphthyridine carboxylic acids in free base form
PCT/US1996/005899 WO1996037475A1 (en) 1995-05-26 1996-04-26 Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form

Publications (2)

Publication Number Publication Date
EE9700290A true EE9700290A (et) 1998-06-15
EE03522B1 EE03522B1 (et) 2001-10-15

Family

ID=23795530

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700290A EE03522B1 (et) 1995-05-26 1996-04-26 Meetod kinoloonkarboksüülhapete ja naftüridiinkarboksüülhapete saamiseks vabade aluste kujul

Country Status (18)

Country Link
US (2) US5602254A (et)
EP (1) EP0828714B1 (et)
JP (1) JPH11505835A (et)
AT (1) ATE199146T1 (et)
CA (1) CA2220080C (et)
CZ (1) CZ289107B6 (et)
DE (1) DE69611782T2 (et)
DK (1) DK0828714T3 (et)
EE (1) EE03522B1 (et)
ES (1) ES2156277T3 (et)
GR (1) GR3035818T3 (et)
HU (1) HUP9901338A3 (et)
MX (1) MX9708562A (et)
NZ (1) NZ307053A (et)
PL (1) PL184063B1 (et)
PT (1) PT828714E (et)
SK (1) SK282666B6 (et)
WO (1) WO1996037475A1 (et)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19716684B4 (de) * 1997-04-21 2009-11-26 Deep Blue Technology Ag Anker-/Ankerketten-Überwachungsvorrichtung
EP2275141A1 (en) 1999-03-17 2011-01-19 Daiichi Pharmaceutical Co., Ltd. Tastemasked pharmaceutical compositions
MX2007000336A (es) * 2004-07-02 2007-03-28 Daiichi Seiyaku Co Composicion medicinal que contiene quinolona.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
DE3248507A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen Mikrobizide mittel auf chinoloncarbonsaeure basis
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
US4771054A (en) * 1985-01-23 1988-09-13 Warner-Lambert Company Antibacterial agents
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent
RO101477A2 (ro) * 1988-06-01 1991-11-18 Intreprinderea Textila, Timisoara, Judetul Timis, Ro Procedeu de obtinere a 3,3'-imino-bis-propionamidei
US4950787A (en) * 1988-08-24 1990-08-21 Monsanto Company Chemical process
US4867901A (en) * 1988-08-24 1989-09-19 Bosch Richard J Improved process for reacting salts of D,L-tartaric and maleic acid in the production of ether carboxylate mixtures
US5290794A (en) * 1992-10-27 1994-03-01 Warner Lambert Co. Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms

Also Published As

Publication number Publication date
EP0828714A1 (en) 1998-03-18
AU5630996A (en) 1996-12-11
PT828714E (pt) 2001-05-31
GR3035818T3 (en) 2001-07-31
ATE199146T1 (de) 2001-02-15
NZ307053A (en) 1998-12-23
CZ366797A3 (cs) 1998-05-13
PL323527A1 (en) 1998-03-30
WO1996037475A1 (en) 1996-11-28
EP0828714B1 (en) 2001-02-14
US5602254A (en) 1997-02-11
DE69611782D1 (de) 2001-03-22
PL184063B1 (pl) 2002-08-30
HUP9901338A2 (hu) 2000-04-28
US5783585A (en) 1998-07-21
SK282666B6 (sk) 2002-11-06
AU698104B2 (en) 1998-10-22
MX9708562A (es) 1997-12-31
JPH11505835A (ja) 1999-05-25
HUP9901338A3 (en) 2002-10-28
ES2156277T3 (es) 2001-06-16
DE69611782T2 (de) 2001-06-21
EE03522B1 (et) 2001-10-15
SK156497A3 (en) 1998-03-04
CA2220080A1 (en) 1996-11-28
DK0828714T3 (da) 2001-03-26
CZ289107B6 (cs) 2001-11-14
CA2220080C (en) 2006-11-21

Similar Documents

Publication Publication Date Title
FI906438A (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
EP1065203A3 (en) Heterocyclic compounds as retinoic acid receptor antagonists
NO177004C (no) Analogifremgangsmåte for fremstilling av 7-substituerte derivater av 3,5-dihydroksyhept-6-ynsyre
ATE94547T1 (de) Pharmazeutische zubereitung enthaltend eine tetrahydropyrrolverbindung als aktiven bestandteil und verfahren zur herstellung dieser tetrapyrrolverbindung.
TNSN90003A1 (fr) Derives de 2-aminopyrimidinones utiles notamment comme antagonistes des neurotransmetteurs et procede pour leur preparation
PH24199A (en) Derivatives of quinoline carboxylic acid,pharmaceutical composition containing same and process of preparing same
BG92179A (bg) Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения
IE45439L (en) Penicillanic acid derivatives
BR9408392A (pt) Derivados de ácidos arilacéticos e sua utilização como fungicidas
DE69111355D1 (de) Verfahren zur Herstellung von granulierter Zitronensäure und ihrer Salze.
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
SE8900827D0 (sv) Nya foereningar av salttyp samt foerfarande foer framstaellning av desamma
EE9700290A (et) Meetod kinoloonkarboksüülhapete ja naftüridiinkarboksüülhapete saamiseks vabade aluste kujul
DE69424447D1 (de) Verfahren zur herstellung von aminoxyd tenside enthaltenden festen zusammensetzungen
IL93161A0 (en) 3-phenyl-5,6-dihydrobenz(c)acridine-7-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
HU901570D0 (en) Process for the preparation of azetidinyl-pyridonecarboxylic acid derivatives and pharmaceutical compositions containing such compounds
PT78776A (fr) Procede de preparation de derives de l'acide bicyclo(3.2.1.)carboxylique et de compositions pharmaceutiques les contenant
EP0012072A3 (en) Beta-lactones derived from 2-hydroxycyclopentane carboxylic acid, process for their preparation, pharmaceutical compositions containing them; 2-hydroxycyclopentane carboxylic acid derivatives and related beta-lactones
MA21913A1 (fr) Procede de preparation de derives amino-oligohydroxy inhibiteurs de la renine .
ES8407021A1 (es) Un procedimiento para la preparacion de derivados de acido 5-oxo-2-pirrolidinpropanoico.
KR890007731A (ko) 생물학적으로 매우 유용한 형태의 철을 함유한 단백질 유도체, 그의 제조 및 이 화합물을 함유하는 제약 조성물
JPS6183159A (ja) Ｎ−アセチルインドリン−２−カルボン酸のラセミ化方法
TH468A (th) สารดีริเวทีฟใหม่ ฮาโลวินคาโมนและขบวนการเตรียม
RU94046014A (ru) Диаминовые соли клавулановой кислоты
TH896EX (th) อนุพันธุ์เซฟฟาโลสปอริน

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

LD4A Amendment in the specification
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

MM4A Lapsed by not paying the annual fees

Effective date: 20050426